We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Dragon
Careers
Categories: Corporate and commercial, Health Care, Information and Communication Technology, Life Sciences, Pharma, Biotech, Startup Desk, Deals & Cases
Ikerian, a healthcare software platform company that organizes multimodal data at-scale, closes the first tranche of USD 8m Series B Financing to advance its AI platform alongside. The Series B Financing Round is led by strategic investor Sanoptis with participation of the existing investors Topcon Healthcare, Zürcher Kantonalbank and Verve Ventures. Alongside the equity investment, Ikerian and Sanoptis have entered into a commercial agreement to support the distribution of the RetinAI Discovery® platform and its AI models at-scale within the European Sanoptis network. The AI and imaging platform is aimed at improving diagnostic and treatment pathways towards personalized patient care.
VISCHER advises Ikerian with Matthias Staehelin (Partner) and Timothy Woodtli (Associate), both Corporate/M&A.
Author: Matthias Staehelin
Attorney at Law and Civil Law Notary (BS/BL)
Attorney at Law
Driven by the ideal of creditor protection, Switzerland introduced a solvency test for all companies...
Mininavident AG, in Liestal, developer and manufacturer of the world’s smallest dynamic navigation...
Tybourne Capital Management, a global, growth-oriented, fundamental equity investor in public and...
